Hepatology
News
Ledipasvir-sofosbuvir plus ribavirin in advanced HCV does well
Key clinical point: Ledipasvir-sofosbuvir plus ribavirin for 12 weeks achieved high SVR rates among patients with hepatitis C virus infection and...
News
Less posttransplant primary biliary cirrhosis with preventive UDCA
Key clinical point: Treatment with prophylactic ursodeoxycholic acid might help prevent recurrent primary biliary cirrhosis after liver...
News
Cirrhosis in HCV often goes unreported
More than 28% of patients with chronic hepatitis C virus infection met at least one criterion for cirrhosis, while only 7% had biopsy confirmation...
News
Online resource provides updated HCV tx guidelines
News
FDA approves Daklinza for HCV genotype 3 infections
News
FDA approves oral interferon-free treatment for genotype 4 HCV infection
Conference Coverage
VIDEO: Nivolumab puts brakes on advanced liver cancer
Conference Coverage
DDW: Gestational diabetes linked to increased NAFLD risk in middle age
Key clinical point: Gestational diabetes could be used to identify young women at increased risk of having non-alcoholic fatty liver disease (...
Conference Coverage
VIDEO: Stroop app predicts hepatic encephalopathy
The Stroop App is a smartphone screening tool that tests the patient’s cognitive speed and flexibility, which physicians can administer themselves...
Conference Coverage
Consider HCV ‘a cardiovascular risk factor’
Key clinical point: Chronic HCV infection was strongly linked to CV outcome and needs to be considered a CV risk factor. Major finding: Adjusted...